Synapse Medicine

📍 Bordeaux, France🗓 Founded 2017👥 78 employees💰 Last funded Apr 2022
At Synapse Medicine, we believe in medication success, and are dedicated to creating the technology that makes it possible for everyone. To achieve this goal, we have built an extensive global knowledge base for medication using algorithms to ensure the most reliable, up-to-date data. On the front-end, Synapse Medicine provides a SaaS platform and UI components that are used to prescribe, dispense, and manage medications across the entire patient journey. Synapse is working with world-leading hospitals and digital health companies in the United States, Europe, and Japan to transform today’s medication regimens into tomorrow’s medication success.
6
Total investors
2
Early stage
4
Mid stage
0
Late stage
2017
Founded
Investor geography1 country
France
6
Investor activity2018–2022 · investors recorded per year
20181201912020120223
Recent (last 2y)Earlier
Frequently asked questions
Who invested in Synapse Medicine?
Synapse Medicine has 6 investors on record on gritt.io, including 2 early-stage backers, 4 mid-stage.
When did Synapse Medicine last raise funding?
The most recent investment in Synapse Medicine recorded on gritt.io was in April 2022.
When was Synapse Medicine founded?
Synapse Medicine was founded in 2017.
What industry is Synapse Medicine in?
Synapse Medicine operates in Information Services. Find similar Information Services investors on gritt.io.
Where is Synapse Medicine based?
Synapse Medicine is headquartered in Bordeaux, France.